TUBGCP3 Antibody

What is TUBGCP3 and why is it significant in cellular research?

TUBGCP3 (Tubulin, gamma Complex Associated Protein 3) is a critical component of the gamma-tubulin ring complex (γTuRC), which serves as a microtubule nucleation template essential for centrosome function. This protein plays a fundamental role in microtubule organization and cell division, making it an important target for studying cellular processes such as:

• Mitotic spindle formation

• Centrosome duplication and function

• Microtubule nucleation mechanisms

• Cell cycle progression

Research has demonstrated that TUBGCP3 interacts with γ-tubulin through its C-terminal domain to form functional γTuRC complexes located at the centrosome during mitosis . This interaction is critical for proper spindle formation and chromosome segregation, with disruptions leading to mitotic arrest and subsequent cellular abnormalities .

What types of TUBGCP3 antibodies are currently available for research?

Multiple TUBGCP3 antibodies have been developed for research applications, offering versatility for different experimental approaches:

When selecting an antibody, researchers should consider the specific epitope targeted, as this affects both specificity and application suitability. For example, antibodies targeting the C-terminal domain may be more effective for studying TUBGCP3-γ-tubulin interactions, as this region has been shown to mediate this binding .

How should TUBGCP3 antibodies be optimized for Western blot applications?

For optimal Western blotting results with TUBGCP3 antibodies, implement the following methodological approach:

• Sample preparation:

  • Use appropriate lysis buffers containing protease inhibitors to prevent degradation

  • For cell lines, direct lysis in Laemmli buffer can provide consistent results

  • Expected molecular weight of TUBGCP3 is approximately 103.6 kDa

• Dilution optimization:

  • Start with manufacturer's recommended dilution (typically 1:500-1:2000 for polyclonal antibodies )

  • For monoclonal antibodies, a dilution of 1:500 is generally recommended

  • Perform a dilution series to determine optimal signal-to-noise ratio

• Incubation conditions:

  • Primary antibody: Incubate overnight at 4°C for optimal binding

  • Secondary antibody: 1-2 hours at room temperature is typically sufficient

  • Include proper washing steps (3-5 times for 5-10 minutes) between antibody incubations

• Controls:

  • Include positive control samples (e.g., K562 cells shown to express TUBGCP3 )

  • Consider using TUBGCP3 knockout/knockdown samples as negative controls when available

When troubleshooting weak or absent signals, consider that TUBGCP3 expression may be cell cycle-dependent, with higher expression during mitosis when centrosome function is critical .

What are the best methodological approaches for studying TUBGCP3 in tissue sections?

When investigating TUBGCP3 in tissue sections, consider these methodological guidelines:

• Fixation method selection:

  • Paraformaldehyde (4%) is generally effective for preserving TUBGCP3 antigenicity

  • For dual localization studies with microtubules, methanol fixation may better preserve microtubule structures

• Antigen retrieval optimization:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) is often effective

  • For formalin-fixed tissues, more aggressive retrieval methods may be necessary

• Antibody application strategy:

  • For co-localization studies with centrosomal markers:

    • Pair TUBGCP3 antibodies with antibodies against γ-tubulin or centrin

    • Use sequential staining if both primary antibodies are from the same host species

  • For cell cycle studies:

    • Combine with PH3 (phospho-histone H3) to identify mitotic cells

    • BrdU incorporation can help distinguish S-phase from G2/M cells

• Image acquisition considerations:

  • Use confocal microscopy for precise co-localization analysis

  • Z-stack imaging is essential for accurate assessment of centrosomal structures

Research has demonstrated that in normal tissues, TUBGCP3 typically appears as distinct foci at the centrosome. In contrast, studies in zebrafish mutants have revealed that Tubgcp3 deficiency results in abnormal distribution patterns with monopolar rather than bipolar spindles .

How can researchers distinguish between specific and non-specific TUBGCP3 antibody binding?

Addressing specificity concerns requires systematic validation:

• Multiple antibody validation approach:

  • Use antibodies targeting different epitopes of TUBGCP3 (N-terminal, C-terminal, internal regions)

  • Compare staining patterns between monoclonal and polyclonal antibodies

  • Expected concordance in localization patterns indicates specificity

• Genetic validation methods:

  • CRISPR/Cas9 knockout validation:

    • Compare antibody signal in wild-type versus TUBGCP3 knockout cells

    • Complete signal loss in knockout confirms specificity

  • siRNA/shRNA knockdown:

    • Quantify signal reduction proportional to knockdown efficiency

    • Western blot showing both reduced TUBGCP3 and corresponding reduction in immunostaining

• Blocking peptide experiments:

  • Pre-incubate antibody with immunizing peptide

  • Specific binding should be competitively inhibited

  • Non-specific binding will remain relatively unchanged

• Expected localization pattern analysis:

  • In interphase cells: TUBGCP3 should concentrate at centrosomes

  • In mitotic cells: TUBGCP3 should localize to spindle poles

  • Aberrant patterns may indicate non-specific binding or technical issues

Research in zebrafish has demonstrated that specific TUBGCP3 staining shows colocalization with γ-tubulin at the centrosome in wild-type cells, while in tubgcp3 mutants, abnormal distribution patterns can be observed with γ-tubulin appearing as single foci in the center of arrested mitotic cells or as scattered foci .

What are the critical considerations when interpreting contradictory results from different TUBGCP3 antibodies?

When faced with discrepant results between different TUBGCP3 antibodies, implement this analytical framework:

• Epitope mapping analysis:

  • Compare the target regions of each antibody

  • Discrepancies may reflect:

    • Differential accessibility of epitopes in various experimental conditions

    • Post-translational modifications masking specific epitopes

    • Protein-protein interactions at specific domains

• Isoform-specific detection assessment:

  • Human TUBGCP3 has multiple transcript variants

  • Verify which isoforms each antibody is expected to detect

  • Cross-reference with expression data in your experimental system

• Methodological variables evaluation:

  • Fixation effects: Some epitopes may be sensitive to specific fixatives

  • Antigen retrieval: Different methods may preferentially expose certain epitopes

  • Detection systems: Secondary antibody sensitivity and specificity differences

• Complementary technique validation:

  • Combine antibody-based detection with:

    • Fluorescent protein tagging (e.g., GFP-TUBGCP3)

    • Proximity ligation assays for protein interaction studies

    • Mass spectrometry validation of immunoprecipitated proteins

Published research has used complementary approaches such as co-immunoprecipitation to validate TUBGCP3 interactions with γ-tubulin . In these studies, the C-terminal domain (amino acids 552-906) of TUBGCP3 was found to be critical for γ-tubulin binding, while the N-terminal domain (amino acids 1-551) did not show binding activity .

How can TUBGCP3 antibodies be utilized to investigate centrosome abnormalities in disease models?

TUBGCP3 antibodies can provide valuable insights into centrosomal dysfunction in various disease contexts:

• Cancer research applications:

  • Quantitative assessment of centrosome amplification:

    • Count TUBGCP3-positive foci per cell

    • Measure size and intensity of TUBGCP3 signals

  • Correlate centrosomal abnormalities with:

    • Chromosomal instability metrics

    • Aneuploidy measurements

    • Invasive/metastatic potential

• Neurodevelopmental disorder investigations:

  • The zebrafish tubgcp3 mutant exhibits microcephaly-like phenotypes , suggesting relevance to:

    • Analysis of neural progenitor proliferation

    • Assessment of mitotic spindle orientation in neural stem cells

    • Correlation of centrosomal defects with brain size reduction

• Cell cycle checkpoint studies:

  • Co-staining protocols:

    • TUBGCP3 + PH3 to identify mitotic cells

    • TUBGCP3 + γ-H2AX to detect DNA damage response activation

    • TUBGCP3 + BrdU to assess S-phase progression

• Methodological approach for quantitative analysis:

  • High-content imaging:

    • Automate detection of TUBGCP3-positive structures

    • Measure intensity, number, and morphology parameters

    • Correlate with cell cycle markers and apoptotic indicators

Research in zebrafish has demonstrated that tubgcp3 mutation leads to monopolar spindle formation, mitotic arrest, and subsequent apoptosis of retinal progenitor cells . These findings suggest TUBGCP3 antibodies can be valuable tools for investigating similar mechanisms in other systems, particularly those related to centrosome-associated diseases.

What approaches should be used to study dynamic TUBGCP3 localization during the cell cycle?

For advanced cell cycle-related TUBGCP3 studies, implement these methodological strategies:

• Fixed-cell time course analysis:

  • Synchronize cells using established methods:

    • Double thymidine block (G1/S boundary)

    • Nocodazole treatment (prometaphase)

    • Mitotic shake-off (early M phase)

  • Fix cells at defined intervals post-release

  • Co-stain with TUBGCP3 antibody and:

    • Cell cycle markers (Cyclin B1, Cyclin E, etc.)

    • Centrosome markers (γ-tubulin, centrin)

    • Mitotic spindle markers (α-tubulin)

• Live-cell imaging approaches:

  • Generate stable cell lines expressing:

    • TUBGCP3-GFP fusion proteins

    • Fluorescently tagged centrosome markers

  • Use spinning disk confocal microscopy for:

    • Long-term imaging with minimal phototoxicity

    • Capture dynamics at 2-5 minute intervals

    • 3D reconstruction of centrosome structures

• Advanced co-localization analysis:

  • Super-resolution microscopy techniques:

    • Structured illumination microscopy (SIM)

    • Stimulated emission depletion (STED) microscopy

  • Quantitative co-localization metrics:

    • Pearson's correlation coefficient

    • Manders' overlap coefficient

    • Distance-based measurements

• Functional perturbation strategies:

  • Acute protein depletion:

    • Auxin-inducible degron system

    • Targeted protein degradation approaches

  • Monitor resulting changes in:

    • Spindle formation dynamics

    • Centrosome duplication timing

    • Microtubule nucleation rates

Research in zebrafish has revealed that loss of TUBGCP3 function causes mitotic arrest with monopolar spindles, where microtubules array radially from the center with condensed chromosomes at the periphery . Similar approaches could be applied to mammalian systems to investigate TUBGCP3's role in spindle dynamics and cell cycle progression.

How can researchers effectively use TUBGCP3 antibodies to study its role in microtubule nucleation?

For investigating TUBGCP3's function in microtubule nucleation, employ these research strategies:

• Microtubule regrowth assays:

  • Protocol outline:

    • Depolymerize microtubules with cold treatment or nocodazole

    • Wash out drug or return to 37°C to allow regrowth

    • Fix cells at short intervals (15s, 30s, 1min, 2min, 5min)

    • Co-stain for TUBGCP3 and α-tubulin

  • Analysis approach:

    • Quantify microtubule aster formation rate

    • Measure aster size and microtubule density

    • Assess TUBGCP3 recruitment to nucleation sites

• In vitro reconstitution experiments:

  • Components required:

    • Purified γ-tubulin complex components

    • Fluorescently labeled tubulin

    • Glass coverslips with appropriate coating

  • Data collection:

    • Total internal reflection fluorescence (TIRF) microscopy

    • Measure nucleation frequency and growth rates

    • Compare wild-type vs. mutant TUBGCP3

• Structure-function relationship studies:

  • Domain-specific analysis:

    • Generate truncation or point mutation constructs

    • Rescue experiments in TUBGCP3-depleted cells

    • Identify domains critical for centrosome localization vs. nucleation activity

  • Co-immunoprecipitation studies:

    • Use domain-specific antibodies for pulldown experiments

    • Identify interaction partners for different TUBGCP3 regions

    • Map binding sites for γ-tubulin complex components

Research has demonstrated that TUBGCP3 interacts with γ-tubulin through its C-terminal domain, which is crucial for forming functional γ-TuRC complexes . This interaction is essential for proper microtubule nucleation and spindle formation, with disruption leading to mitotic defects and developmental abnormalities in model organisms .

How can researchers best utilize TUBGCP3 antibodies to study its role in developmental processes?

For developmental studies involving TUBGCP3, implement these methodological approaches:

• Embryonic tissue analysis protocol:

  • Sample preparation considerations:

    • Optimize fixation for developmental stages (4% PFA typically effective)

    • Consider whole-mount approaches for early embryos

    • Use vibratome sections for thick tissues

  • Staining strategy:

    • TUBGCP3 antibody combined with:

      • Progenitor cell markers (Sox2, Nestin, etc.)

      • Differentiation markers

      • Cell cycle indicators

• Quantitative developmental phenotyping:

  • For TUBGCP3 mutant/knockdown models:

    • Document gross morphological changes (e.g., brain size, eye development)

    • Quantify proliferation defects in stem/progenitor populations

    • Assess cell cycle parameters in affected tissues

• Tissue-specific manipulation approaches:

  • Conditional knockout/knockdown strategies:

    • Cre-loxP systems for tissue-specific deletion

    • Inducible shRNA for temporal control

  • Analysis methods:

    • Lineage tracing combined with TUBGCP3 immunostaining

    • Clonal analysis of TUBGCP3-deficient cells

    • Time-course studies of developmental progression

Research in zebrafish has shown that tubgcp3 mutation leads to significant developmental defects, including microcephaly-like phenotypes with reduced brain and eye size, becoming progressively more severe between 3-5 days post-fertilization . In this model, retinal progenitor cells exhibited mitotic arrest with monopolar spindles, leading to apoptosis and compromised tissue development .

What are the most effective protocols for using TUBGCP3 antibodies in cancer research studies?

For cancer-focused TUBGCP3 investigations, implement these specialized approaches:

• Tissue microarray analysis methodology:

  • Staining protocol optimization:

    • Test multiple TUBGCP3 antibodies (polyclonal and monoclonal)

    • Compare epitope retrieval methods

    • Use multiplexed immunofluorescence for co-localization studies

  • Scoring system development:

    • Quantify TUBGCP3-positive foci per cell

    • Assess abnormal patterns (size, number, distribution)

    • Correlate with clinical parameters and outcomes

• Cancer cell line panel screening:

  • Standardized analysis approach:

    • Western blot quantification of TUBGCP3 levels

    • Immunofluorescence characterization of centrosome abnormalities

    • Correlation with genomic instability metrics

  • Advanced image analysis:

    • Machine learning classification of centrosome phenotypes

    • High-content screening across cell line panels

    • Correlation with drug sensitivity data

• Functional studies in cancer models:

  • Experimental design:

    • TUBGCP3 overexpression/knockdown in cancer cells

    • Assessment of proliferation, migration, and invasion

    • In vivo tumor formation and metastasis studies

  • Mechanistic investigation:

    • Co-immunoprecipitation with TUBGCP3 antibodies

    • Mass spectrometry analysis of interacting partners

    • Phosphorylation status analysis during cell cycle progression

Research indicates that centrosome abnormalities, including alterations in proteins like TUBGCP3, are frequently observed in many cancer types and may contribute to chromosomal instability and aneuploidy . Understanding these mechanisms could potentially identify new therapeutic targets or prognostic markers.

How can researchers develop effective co-immunoprecipitation protocols using TUBGCP3 antibodies?

For robust TUBGCP3 co-immunoprecipitation experiments, follow this detailed methodological approach:

• Lysis buffer optimization:

  • Recommended composition:

    • Base buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl

    • Detergent: 0.5% NP-40 or 1% Triton X-100 (maintain complex integrity)

    • Protease inhibitors: Complete protease inhibitor cocktail

    • Phosphatase inhibitors: 10 mM NaF, 1 mM Na₃VO₄

  • Critical considerations:

    • Detergent strength affects complex stability

    • Salt concentration influences interaction specificity

    • Buffer temperature impacts complex preservation

• Antibody selection and validation:

  • For capturing TUBGCP3:

    • Test multiple antibodies against different epitopes

    • Validate precipitation efficiency by Western blot

    • Consider antibody orientation (direct coupling vs. protein A/G beads)

  • For detecting interactions:

    • Use antibodies raised in different host species

    • Validate specificity with appropriate controls

    • Consider native vs. denatured epitope recognition

• Protocol optimization steps:

  • Pre-clearing strategy:

    • Incubate lysates with beads alone to reduce non-specific binding

    • Include isotype control antibodies as negative controls

  • IP conditions:

    • Incubation time: 2-4 hours or overnight at 4°C

    • Antibody amount: Typically 2-5 μg per mg of protein lysate

    • Washing stringency: Balanced to maintain specific interactions

• Validation approaches:

  • Reciprocal co-IP:

    • Immunoprecipitate with γ-tubulin antibody, detect TUBGCP3

    • Compare results with TUBGCP3 IP detecting γ-tubulin

  • Domain mapping:

    • Use truncated constructs to identify interaction regions

    • Cross-validate with published interaction sites

Research has used co-immunoprecipitation to demonstrate that TUBGCP3 interacts with γ-tubulin through its C-terminal domain (amino acids 552-906), while the N-terminal domain (amino acids 1-551) does not show this interaction . This approach can be adapted to investigate other TUBGCP3 interaction partners and regulatory mechanisms.

What are the most sensitive methods for detecting low abundance TUBGCP3 in experimental samples?

For detecting TUBGCP3 in challenging or low-abundance samples, implement these advanced techniques:

• Enhanced Western blot sensitivity protocols:

  • Signal amplification methods:

    • HRP-conjugated polymers instead of standard secondary antibodies

    • Tyramide signal amplification systems

    • Enhanced chemiluminescence substrates (Super ECL, Femto ECL)

  • Sample preparation refinements:

    • Centrosome isolation or enrichment protocols

    • Immunoprecipitation prior to Western blotting

    • Fractionation to concentrate centrosomal proteins

• Proximity ligation assay (PLA) implementation:

  • Experimental design:

    • Probe for TUBGCP3 and known interactors (γ-tubulin, other GCPs)

    • Each interaction generates a single fluorescent spot

    • Single-molecule sensitivity ideal for low abundance proteins

  • Controls required:

    • Single primary antibody controls

    • Non-interacting protein pairs as negative controls

    • Known interactors as positive controls

• Mass spectrometry-based approaches:

  • Sample enrichment strategies:

    • Immunoprecipitation with TUBGCP3 antibodies

    • Centrosomal fraction isolation

    • Crosslinking to stabilize transient interactions

  • MS techniques for low abundance proteins:

    • Selected reaction monitoring (SRM)

    • Parallel reaction monitoring (PRM)

    • Data-independent acquisition (DIA)

• Super-resolution microscopy applications:

  • Recommended techniques:

    • Stochastic optical reconstruction microscopy (STORM)

    • Photoactivated localization microscopy (PALM)

    • Expansion microscopy for physical magnification

  • Analysis considerations:

    • Quantitative assessment of focal intensity

    • Precise localization relative to centrosomal landmarks

    • 3D reconstruction for comprehensive spatial mapping

These advanced techniques have been successfully applied in detecting and characterizing low-abundance centrosomal proteins like TUBGCP3 in various experimental systems, enabling more sensitive detection than conventional methods .

How can researchers effectively design multiplexed immunostaining protocols involving TUBGCP3 antibodies?

For complex co-localization studies with TUBGCP3, implement these multiplexed staining strategies:

• Antibody panel design considerations:

  • Host species selection:

    • Choose primary antibodies from different host species when possible

    • For same-species antibodies, consider direct conjugation to fluorophores

    • Use isotype-specific secondaries for same-species primaries

  • Recommended combinations:

    • TUBGCP3 + γ-tubulin + α-tubulin (centrosome-spindle relationships)

    • TUBGCP3 + centrin + PH3 (centrosome-cell cycle studies)

    • TUBGCP3 + γ-H2AX + TUNEL (mitotic arrest and cell death pathway)

• Sequential staining protocol development:

  • For challenging combinations:

    • Apply first primary and secondary antibodies

    • Fix with 4% PFA to stabilize immune complexes

    • Block remaining binding sites

    • Apply second round of antibodies

  • Controls needed:

    • Single-stain controls for spectral bleed-through

    • Secondary-only controls for background assessment

    • Absorption controls with immunizing peptides

• Quantitative co-localization analysis:

  • Image acquisition parameters:

    • Nyquist sampling for optimal resolution

    • Consistent exposure settings across samples

    • Z-stack acquisition for 3D assessment

  • Analysis approaches:

    • Object-based co-localization (centrosome foci counting)

    • Intensity correlation analysis

    • Distance measurement between structures

Research in zebrafish has used multiplexed immunostaining combining TUBGCP3/γ-tubulin with cell cycle markers (PH3, BrdU) and cell death indicators (TUNEL, γ-H2AX) to demonstrate that TUBGCP3-deficient retinal progenitor cells undergo mitotic arrest followed by apoptosis .

What are the best approaches for studying the interactions between TUBGCP3 and other components of the γ-tubulin ring complex?

For comprehensive analysis of TUBGCP3 within the γ-TuRC, implement these research strategies:

• Biochemical complex characterization:

  • Sucrose gradient centrifugation:

    • Separate native complexes by size

    • Detect TUBGCP3 distribution across fractions by Western blot

    • Compare with other γ-TuRC components (γ-tubulin, GCP2, GCP4)

  • Blue native PAGE:

    • Preserve native complexes during electrophoresis

    • Perform second dimension SDS-PAGE for component analysis

    • Western blot to identify TUBGCP3-containing complexes

• Structural analysis approaches:

  • Cryo-electron microscopy:

    • Purify γ-TuRC complexes via immunoprecipitation

    • Determine TUBGCP3 position within the complex

    • Map structural domains involved in interactions

  • Crosslinking mass spectrometry:

    • Identify direct interaction surfaces between components

    • Map proximity relationships within the complex

    • Validate with domain-specific antibodies

• Domain mapping experiments:

  • Truncation/deletion analysis:

    • Generate constructs lacking specific TUBGCP3 domains

    • Assess complex assembly and function

    • Use domain-specific antibodies to validate findings

  • Point mutation studies:

    • Target conserved residues in interaction domains

    • Assess effects on complex integrity and function

    • Correlate with known structural information

Co-immunoprecipitation studies have demonstrated that TUBGCP3 interacts with γ-tubulin through its C-terminal domain (amino acids 552-906) . This approach can be extended to investigate interactions with other γ-TuRC components, helping to build a comprehensive understanding of complex assembly and function.